Fluciclovine F-18

CHEBI:CHEBI_756791

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
nui
N0000175869
pharm_class_epc
Radioactive Diagnostic Agent [EPC]
pharm_class
Positron Emitting Activity [MoA]
labeler_name
Blue Earth Diagnostics
manufacturer_name
Blue Earth Diagnostics
pharm_class_moa
Positron Emitting Activity [MoA]
marketing_start_date
20160527
package_marketing_start_date
20160527
generic_name
Fluciclovine F-18
brand_name
Axumin
brand_name_base
Axumin
product_ndc
69932-001
application_number
NDA208054
spl_id
09a64dae-597b-1d75-e063-6294a90a1f6a
active_ingredient_name
FLUCICLOVINE F-18
active_ingredient_strength
221 mCi/mL
package_ndc
69932-001-50
package_description
50 mL in 1 VIAL, MULTI-DOSE (69932-001-50)
unii
38R1Q0L1ZE
spl_set_id
389a502e-a7d5-43dd-b6bf-f022ff23f3b9
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class